Nasdaq

Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab

ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the ...
FierceBiotech

Abbott's Panbio antigen test obtains new European approvals for mass COVID-19 screening

Abbott has received new COVID-19 diagnostic approvals in Europe for its rapid Panbio antigen test, clearing it for self-performed screening under supervision as well as widespread use by people who ...
Nasdaq

Abbott (ABT) CE-Marked Panbio Test Now Widely Offered in Europe

Abbott Laboratories ABT recently received the CE Mark for its Panbio COVID-19 Antigen Self-Test for sale directly to consumers. The test, which delivers results in a few minutes, can be used to detect ...
FierceBiotech

Abbott's rapid antigen COVID-19 test cleared in Europe for at-home, direct-to-consumer sales

Even as Abbott continues to anticipate a steep drop-off in its COVID-19 testing sales boom—and recently updated its financial projections for the year to reflect that—testing demand has yet to ...